ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 954

The Relationship Between Osteoarthritis and Cardiovascular Disease: Results from a Population-Based Cohort

Lauren King1, Tetyana Kendzerska1,2,3 and Gillian Hawker1,2,3, 1Department of Medicine, University of Toronto, Toronto, ON, Canada, 2Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, ON, Canada, 3Institute for Clinical Evaluative Sciences, Toronto, ON, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Cardiovascular disease, Inflammation, osteoarthritis and physical function

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Osteoarthritis - Clinical Aspects: Treatments and Epidemiology

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose:
Symptomatic osteoarthritis (OA) and cardiovascular
disease (CVD) commonly co-exist. Our aim was to determine the extent to which
this relationship is explained by common risk factors (age and obesity),
metabolic factors and self-reported functional limitations.

Methods:
A population cohort aged ³55 years was recruited from
1996-98 from two communities. Age, sex, height and weight, self-reported medical
comorbidities, joint complaints and functional limitations (difficulty with
stair climbing, walking, and gripping) were collected by survey. Subjects with
inflammatory arthritis, rheumatic disease and medical neurological conditions
associated with functional disability were excluded. OA was defined as (1) swelling,
pain, or stiffness in any joint lasting 6 weeks in the past 3 months; and (2)
indication on the homunculus that a knee, hand and/or hip was “troublesome”. CVD
was defined as self-reported angina, heart disease, myocardial infarction,
coronary reperfusion, heart failure, stroke, transient ischemic
attack‎ and/or carotid disease. Participants were classified into
8 mutually exclusive joint groups based on the presence/absence of knee, hand and
hip complaints. Using logistic regression, we examined the relationship of CVD
with knee, hand, and hip complaints, controlling for the following variables
added to our model incrementally: (1) age and body mass index (BMI); (2) sex
and metabolic factors (diabetes, hypertension and dyslipidemia); and (3) functional
limitations (stairs, walking, grip). 

Results:
20,501 participants were included: mean age
68.2±8.5 years, 58.5% female, 51.8% rural-dwelling and mean BMI of 25.9±4.5
kg/m2. Controlling for age and BMI, the prevalence of self-reported
CVD was significantly higher among individuals with a combination of knee, hand
and hip OA (adj odds ratio [OR] 1.42, 1.16 –
1.72, p<0.01); combination of knee and hand OA (adj
OR 1.37, 1.13 – 1.66, p<0.01); and combination of hand and hip OA (adj OR 1.46, 1.07 – 1.97, p=0.02). Further adjustment
for sex and metabolic factors did not substantially impact these relationships.
When functional limitations were entered into the model, the above associations
were attenuated and became non-significant (Figure 1).

Conclusion:
In a large population cohort aged ³55 years, the previously documented relationship
between symptomatic OA (knee, hand, hip) and CVD was confirmed. This
relationship remained robust after controlling for common risk factors and metabolic
factors, but became non-significant after controlling for functional limitations,
suggesting that the predominant mechanism driving cardiovascular risk in people
with OA is functional disability. Further work is needed to investigate effective
ways to improve functional limitations in people with established OA.

Figure
1: Correlates of Self-Reported CVD by Multivariable Logistic Regression Model

Description: Plot of Odds Ratios with 95% Wald Confidence Limits


Disclosure: L. King, None; T. Kendzerska, None; G. Hawker, None.

To cite this abstract in AMA style:

King L, Kendzerska T, Hawker G. The Relationship Between Osteoarthritis and Cardiovascular Disease: Results from a Population-Based Cohort [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-relationship-between-osteoarthritis-and-cardiovascular-disease-results-from-a-population-based-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-relationship-between-osteoarthritis-and-cardiovascular-disease-results-from-a-population-based-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology